Analysis Shows 100 Million Non–COVID-19 Adult Vaccines Potentially Missed
The COVID-19 pandemic had a particularly negative impact on the uptake of non–COVID-19 vaccines for adults in some countries. Even countries with great progress in adult vaccination prior to the pandemic saw a decline after the pandemic.
World Tuberculosis Day: Easing the Continuum of Care Burden
The Bill & Melinda Gates Medical Research Institute has multiple tuberculosis (TB) therapies and a prophylactic vaccine in development, and its chief medical officer, Michael W. Dunne, MD, remains optimistic long-term about the state of clinical care, especially in low-and-middle-income countries.